These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16127194)

  • 1. Exercise after heparin administration: new therapeutic program for patients with-option arteriosclerosis oblitrans.
    Maejima Y; Yasu T; Ueba H; Kobayashi N; Hashimoto S; Kubo N; Kakehashi A; Isobe M; Kawakami M; Saito M
    Circ J; 2005 Sep; 69(9):1099-104. PubMed ID: 16127194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
    Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
    Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and exercise treatment in a patient with arteriosclerosis obliterans.
    Shioji K; Fujita M; Yamada T; Matsuda T; Nohara R; Sasayama S
    Jpn Circ J; 1997 Aug; 61(8):715-8. PubMed ID: 9276778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical features and treatment of arteriosclerosis obliterans with diabetes.
    Tsushima N; Matsuo H; Hayashi T; Homma S
    Diabetes; 1996 Jul; 45 Suppl 3():S101-4. PubMed ID: 8674871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Release of hepatocyte growth factor mediated by heparin].
    Zhu Y; Zhou L; Zhang F; Guo JX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):287-9. PubMed ID: 15205701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration.
    Christidou F; Bamichas G; Galaktidou G; Fragidis S; Gionanlis L; Frangia T; Bischiniotis T; Sombolos K
    Ren Fail; 2008; 30(9):861-4. PubMed ID: 18925524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis obliterans of the lower extremities in Thai patients.
    Mutirangura P; Ruangsetakit C; Wongwanit C; Sermsathanasawadi N; Chinsakchai K
    J Med Assoc Thai; 2006 Oct; 89(10):1612-20. PubMed ID: 17128835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-mediated selective release of hepatocyte growth factor in humans.
    Salbach PB; Brückmann M; Turovets O; Kreuzer J; Kübler W; Walter-Sack I
    Br J Clin Pharmacol; 2000 Sep; 50(3):221-6. PubMed ID: 10971306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arteriosclerosis obliterans (ASO)].
    Koshikawa M; Ikeda U
    Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy.
    Morishita R; Nakamura S; Hayashi S; Taniyama Y; Moriguchi A; Nagano T; Taiji M; Noguchi H; Takeshita S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1999 Jun; 33(6):1379-84. PubMed ID: 10373220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrimental effects of acute heparin administration on ischemic threshold in patients with coronary artery disease.
    Fragasso G; Leonardo F; Piatti P; Monti LD; Sheiban I; Gernone F; Setola E; Pontiroli AE; Chierchia SL
    Ital Heart J; 2000 Jun; 1(6):407-11. PubMed ID: 10929741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
    Fragasso G; Piatti PM; Monti L; Palloshi A; Lu C; Valsecchi G; Setola E; Calori G; Pozza G; Margonato A; Chierchia S
    J Am Coll Cardiol; 2002 Feb; 39(3):413-9. PubMed ID: 11823078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative treatment for patients with intermittent claudication.
    Sugimoto I; Ohta T; Ishibashi H; Iwata H; Yamada T; Tadakoshi M; Hida N; Orimoto Y
    Int Angiol; 2010 Apr; 29(2 Suppl):55-60. PubMed ID: 20357750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease.
    Januszek R; Mika P; Konik A; Petriczek T; Nowobilski R; Niżankowski R
    J Cardiol; 2014 Aug; 64(2):145-51. PubMed ID: 24438856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass.
    Kaisar J; Chen A; Cheung M; Kfoury E; Bechara CF; Lin PH
    Vascular; 2018 Apr; 26(2):117-125. PubMed ID: 28835186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease.
    Kawano T; Saito T; Yasu T; Saito T; Nakamura T; Namai K; Tamemoto H; Kawakami M; Saito M; Ishikawa SE
    Metabolism; 2005 May; 54(5):653-6. PubMed ID: 15877296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia.
    Neville RF; Capone A; Amdur R; Lidsky M; Babrowicz J; Sidawy AN
    J Vasc Surg; 2012 Oct; 56(4):1008-14. PubMed ID: 22677009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.